Highlights•The contribution of pregnancy hypertension to maternal mortality is almost
certainly under-estimated.•Solutions relate to both societal and medical interventions.• …

Pre-eclampsia remains the second leading direct cause of maternal death,> 99% of which
occurs in less developed countries. Over 90 percent of the observed reduction in pre …

Objective The objective is to provide guidelines for the use of antenatal magnesium sulphate
for fetal neuroprotection of the preterm infant. Options Antenatal magnesium sulphate …

Aim Economic appraisal can help guide policy‐making for purchasing decisions, and
treatment and management algorithms for health interventions. We conducted a systematic …

Objective To determine the association of antenatal magnesium sulfate with cerebellar
hemorrhage in a prospective cohort of premature newborns evaluated by magnetic …

Antenatal administration of magnesium sulfate is an important part of the neuroprotective
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …

The neuro-protective effect of antenatal magnesium sulfate on very preterm infants has been
demonstrated in good-quality randomised controlled trials and meta-analyses. Magnesium …

Objective To evaluate the effectiveness and cost-effectiveness of the National PReCePT
Programme (NPP) in increasing use of magnesium sulfate (MgSO4) in preterm births …

Objective To compare two quality improvement (QI) interventions to improve antenatal
magnesium sulphate (MgSO4) uptake in preterm births for the prevention of cerebral palsy …

Objective To investigate the impact of an enhanced QI support programme (ESP) in further
improving the magnesium sulphate (MgSO4) uptake compared to the National PReCePT …